Walvax Biotechnology Co., Ltd.
SHZ: 300142.SZ0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- Shenzhen Stock Exchange
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- CEO
- Yunchun Li
- Employees
- 2,388
- Headquarters
- Kunming, China
- IPO year
- 2010
- Market cap
- CN¥21.4B
- Website
- https://www.walvax.com
Loading 300142…
Loading profile data…Frequently asked questions about 300142
What does Walvax Biotechnology Co., Ltd. (300142.SZ) do?
Walvax Biotechnology Co., Ltd., a biological pharmaceutical company, researches and develops, produces, and sells bio-medicine products in China. The company offers biomedicines, such as vaccines, blood products, and others. It provides Group A, C meningococcal polysaccharide conjugate vaccine for infants below or equal to 2 years preventing dis...
Where does 300142.SZ trade?
Walvax Biotechnology Co., Ltd. (300142.SZ) trades on the Shenzhen Stock Exchange.
What sector is 300142.SZ in?
Walvax Biotechnology Co., Ltd. (300142.SZ) operates in the Healthcare sector, specifically in the Drug Manufacturers - Specialty & Generic industry.
Who is the CEO of Walvax Biotechnology Co., Ltd.?
Yunchun Li is the chief executive officer of Walvax Biotechnology Co., Ltd. (300142.SZ).
Where is Walvax Biotechnology Co., Ltd. headquartered?
Walvax Biotechnology Co., Ltd. is headquartered in China.
Does 300142.SZ pay a dividend?
Yes — Walvax Biotechnology Co., Ltd. (300142.SZ) paid a trailing twelve-month dividend of CNY 0.04 per share. Frequency and ex-dividend dates are tracked on the dividends tab.
When did 300142.SZ go public?
Walvax Biotechnology Co., Ltd. (300142.SZ) completed its initial public offering in 2010.